Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia
- Conditions
- Staphylococcus aureus bacteremia
- Registration Number
- NL-OMON28621
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
Adults with methicillin-sensitive complicated SAB with satisfactory clinical response to initial treatment will be eligible for inclusion.
Exclusion Criteria
Patients with infected prosthetic material or pregnant/lactating will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is a composite of all-cause mortality or bacteriologically confirmed disease relapse.
- Secondary Outcome Measures
Name Time Method Secondary outcomes will include antibiotic-related toxicity, length of hospital admission, perceived quality of life and societal costs.